Johns Hopkins Gets FDA Approval To Test Blood Therapies For COVID-19 Patients
BALTIMORE (WJZ) -- The FDA has approved a clinical trial that will allow researchers at Johns Hopkins University to test a therapy for COVID-19 that uses plasma from recovering patients.
Researchers hope to use this technique to treat critically ill patients and boost the immune systems of healthcare providers and first responders.
CORONAVIRUS COVERAGE:
- What Is A Coronavirus?
- The Symptoms Of Coronavirus And What You Should Do If You Feel Sick
- LIST: EPA Releases Names Of Disinfectants You Can Use Against Coronavirus
- Coronavirus-Related Scams Are Going Around. Here's What To Watch Out For
- What We Know About Coronavirus In Maryland
- Latest coronavirus stories from WJZ
- Coronavirus Resources: How To Get Help In Maryland
Johns Hopkins is leading this research, but nearly two dozen other medical centers and doctors are going to be assisting.
No vaccine or treatment for the virus currently exists.
For the latest information on coronavirus go to the Maryland Health Department's website or call 211. You can find all of WJZ's coverage on coronavirus in Maryland here.
